Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Market conditions right for Unilabs to sell

HBI hears rumour that pan-European laboratory and imaging group Unilabs could sell soon. We explore how its private equity owner Apax could make a much-anticipated exit. 
September 9, 2021

Nordic launches a process for €2bn+ Veonet

Strong rumours reported by HBI back in July that Nordic Capital-backed ophthalmology group Veonet (including Germany's largest operator by revenue Ober Scharrer) would come to market before the autumn have been proven correct. HBI understands the group has launched a process, and a price tag of in excess of €2bn is expected.
September 9, 2021

HCG sells Strand minority stake to Reliance

Indian oncology hospital group HealhCare Global Enterprises (HCG) has sold its minority stake in life sciences company Strand after buying in full its oncology lab and clinical trials business.
September 9, 2021

EU dermatology M&A slows

Investors in the US are pouring money into dermatology, while EU markets remain far quieter. To find out where and why deals are – and aren’t - happening, we round up the latest news from the sector in Europe, including the UK dermatology consultant-led business Dermatology Partnership, Sweden’s leading dermatology provider Diagnostiskt Centrum Hud, and Dermatologikum Hamburg in Germany.
September 9, 2021

Boris breaches election pledge with £12bn tax hike for health and social care

On Tuesday, September 7, Prime Minister Boris Johnson and his UK government announced a new health and social care tax to fund both the NHS and social care. While it is hard for operators to be ungrateful for extra funding in social care, many are asking whether the plan goes far enough. HBI talks to market experts to find out more.
September 7, 2021

Is ‘no jab no job’ policy creating a UK care home staffing crisis?

Reports abound of a looming crisis in recruitment and retention in the UK care home sector when the government’s no jab no job policy comes into force in November. HBI catches up with market expert Clare Connell, founder and CEO of Connell Consulting Limited, who sees a slightly different picture.
September 7, 2021

HBI Deals+Insights briefing October 2021: Connect members

Click here to see your Deals+Insights October 2021 October has a packed double edition which includes Unilabs' impending sale, Nordic's sale process for €2bn Veonet, NMC selling Aspen’s opco to its landlord, Livingbridge buying Everlight, and so much more M&A. It also looks at elections in Germany and what this means for healthcare, plus there's […]
September 5, 2021

HBI Deals+Insights briefing November 2021: Deals+Insights members

Click here to see your Deals+Insights November 2021 For November’s edition, HBI takes a deep delve into Babylon’s business model in light of its recent SPAC merger, and asks what the thinking was behind Icade Santé’s decision to pull its IPO. We also lead on dual processes for pan European ophthalmology group Veonet and German […]
September 3, 2021

Promedica24 continues expansion – sale ‘on the table’

Pan-European homecare group Promedica24 tells HBI that long-term investor ForeVest is considering an exit in the next 1-2 years. Tomasz Brzeziński, CEO and CFO, says that the group has plans to move into Switzerland and Austria as well as diversify its revenue sources in Germany. Brzeziński is one of 100 speakers at HBI 2021, Sept 20-22, the global CEO-level event focused on for-profit healthcare.
September 2, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us